Fermentalg targets 2026 revenue of EUR 20 million, expects sharp H2 acceleration

• Fermentalg kept its 2026 sales target of EUR 20 million, projecting a sharp revenue acceleration in H2.
• H1 2026 revenue totaled EUR 7.4 million versus EUR 7.6 million a year earlier, with higher-margin OmegaRIGINS lipid sales up nearly 20% to about EUR 7 million.
• Aquaculture sales fell 85% in H1, though rising fish oil prices improved the outlook for renewed H2 demand.
• First order for natural blue dye Galdieria Blue set for H2 delivery and revenue recognition, with industrial-scale production planned from early fall 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fermentalg SA published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.